scispace - formally typeset
P

Pallavi Chaturvedi

Researcher at Johns Hopkins University

Publications -  40
Citations -  4229

Pallavi Chaturvedi is an academic researcher from Johns Hopkins University. The author has contributed to research in topics: Metastasis & Biology. The author has an hindex of 20, co-authored 24 publications receiving 3587 citations. Previous affiliations of Pallavi Chaturvedi include University of Nebraska Medical Center & Johns Hopkins University School of Medicine.

Papers
More filters
Journal ArticleDOI

Hypoxia-inducible factors are required for chemotherapy resistance of breast cancer stem cells

TL;DR: Results demonstrate that HIF expression and transcriptional activity are induced by treatment of MDA-MB-231, SUM-149, and SUM-159, which are human TNBC cell lines, as well as MCF-7, which is an ER+/PR+ breast cancer line, with paclitaxel or gemcitabine.
Journal ArticleDOI

Hypoxia-inducible Factor 1 (HIF-1) Promotes Extracellular Matrix Remodeling under Hypoxic Conditions by Inducing P4HA1, P4HA2, and PLOD2 Expression in Fibroblasts

TL;DR: It is demonstrated that hypoxia-inducible factor 1 (HIF-1) is a critical regulator of ECM remodeling by fibroblasts under hypoxic conditions, which induces changes in breast cancer cell morphology, adhesion, and motility that promote invasion and metastasis.
Journal ArticleDOI

Hypoxia-inducible factors and RAB22A mediate formation of microvesicles that stimulate breast cancer invasion and metastasis

TL;DR: Exposure of human breast cancer cells to hypoxia augments MV shedding that is mediated by the HIF-dependent expression of the small GTPase RAB22A, which colocalizes with budding MVs at the cell surface.
Journal ArticleDOI

Hypoxia-inducible factor 1 is a master regulator of breast cancer metastatic niche formation

TL;DR: It is demonstrated that hypoxia-inducible factor 1 (HIF-1) is a critical regulator of breast cancer metastatic niche formation through induction of multiple members of the lysyl oxidase (LOX) family, including LOX, LOX-like 2, and LOx-like 4, which catalyze collagen cross-linking in the lungs before BMDC recruitment.
Journal ArticleDOI

HIF-1-dependent expression of angiopoietin-like 4 and L1CAM mediates vascular metastasis of hypoxic breast cancer cells to the lungs

TL;DR: It is demonstrated that inhibition of hypoxia-inducible factor activity in BrCa cells by RNA interference or digoxin treatment inhibits primary tumor growth and also inhibits the metastasis of Br Ca cells to the lungs by blocking the expression of angiopoietin-like 4 (ANGPTL4) and L1 cell adhesion molecule (L1CAM).